NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 24 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,003,780 | +0.9% | 34,882 | +1.9% | 0.01% | -16.7% |
| Q1 2023 | $2,977,574 | -4.0% | 34,244 | -1.9% | 0.01% | -14.3% |
| Q4 2022 | $3,100,727 | +3.5% | 34,890 | +4.2% | 0.01% | -6.7% |
| Q3 2022 | $2,995,000 | -19.9% | 33,489 | -20.9% | 0.02% | -11.8% |
| Q2 2022 | $3,740,000 | +14.3% | 42,358 | +18.6% | 0.02% | +30.8% |
| Q1 2022 | $3,271,000 | -2.2% | 35,700 | 0.0% | 0.01% | +8.3% |
| Q4 2021 | $3,345,000 | – | 35,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 67,736,000 | $60,446,929 | 4.40% |
| BRAIDWELL LP | 131,834,000 | $117,582,745 | 3.94% |
| DeepCurrents Investment Group LLC | 38,391,000 | $34,368,176 | 1.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 16,861,000 | $14,946,863 | 0.93% |
| Context Capital Management, LLC | 12,489 | $11,139 | 0.82% |
| WOLVERINE ASSET MANAGEMENT LLC | 76,557,000 | $68,630,367 | 0.71% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 3,500,000 | $3,113,250 | 0.47% |
| Aequim Alternative Investments LP | 18,000,000 | $16,054,200 | 0.44% |
| Ionic Capital Management LLC | 2,000,000 | $1,781,555 | 0.42% |
| Verition Fund Management LLC | 27,771,000 | $24,768,955 | 0.39% |